Cargando…

Intravenous Vitamin K1 for the Correction of Prolonged Prothrombin Times in Non-Bleeding Critically Ill Patients: A Prospective Observational Study

The aim of this study was to evaluate the effects of vitamin K1 on various vitamin K-dependent proteins in critically ill patients with prolonged Owren PT. We included critically ill non-bleeding adult patients without liver failure or anticoagulation treatment, with Owren PT > 1.2, who were pres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dahlberg, Sofia, Schött, Ulf, Eriksson, Emilia Ängeby, Tahirsylaj, Yllnor, Schurgers, Leon, Kander, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401696/ https://www.ncbi.nlm.nih.gov/pubmed/34444740 http://dx.doi.org/10.3390/nu13082580

Ejemplares similares

The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study
por: Dahlberg, Sofia, et al.
Publicado: (2021)

Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients
por: Dahlberg, Sofia, et al.
Publicado: (2018)

Effect of hypothermia on haemostasis and bleeding risk: a narrative review
por: Kander, Thomas, et al.
Publicado: (2019)

BLEEDING TENDENCY AND PROTHROMBIN DEFICIENCY IN BILIARY FISTULA DOGS: EFFECT OF FEEDING BILE AND VITAMIN K
por: Smith, H. P., et al.
Publicado: (1938)

Efficacy and safety of activated prothrombin complex concentrate for the reversal of vitamin K antagonist major bleeding
por: Sheikh-Taha, Marwan, et al.
Publicado: (2022)

Clinical outcome of patients with a vitamin K antagonist‐associated bleeding treated with prothrombin complex concentrate
por: Brekelmans, Marjolein P. A., et al.
Publicado: (2017)

Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding
por: Schick, Kerstin S, et al.
Publicado: (2009)

Bleeding complications after central line insertions and the relevance of pre-procedure coagulation tests and blood component therapy
por: Kander, TK, et al.
Publicado: (2013)

Evaluation of Prothrombin Response to Vitamin K as Liver Function Test
por: Wahi, P. N.
Publicado: (1947)

PROTHROMBIN DEFICIENCY THE CAUSE OF BLEEDING IN BILE FISTULA DOGS
por: Hawkins, W. B., et al.
Publicado: (1936)

Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study
por: Schött, Ulf, et al.
Publicado: (2021)

Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study)
por: Tazarourte, Karim, et al.
Publicado: (2014)

Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
por: Yang, Yang, et al.
Publicado: (2021)

PROTHROMBIN DEFICIENCY AND THE BLEEDING TENDENCY IN LIVER INJURY (CHLOROFORM INTOXICATION)
por: Smith, H. P., et al.
Publicado: (1937)

The Two-Stage “Prothrombin” Assay in Study of Bleeding and Clotting Disorders
por: Ferguson, John H., et al.
Publicado: (1955)

Preclinical evaluation of point‐of‐care prothrombin time as a biomarker test to guide prothrombin replacement therapy in coagulopathic bleeding
por: Balendran, Clare A., et al.
Publicado: (2017)

Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis
por: Brekelmans, Marjolein P. A., et al.
Publicado: (2017)

Case report of recurrent bleeding in an infant with isolated prolonged prothrombin time due to congenital factor VII deficiency---a riddle solved
por: Ganguly, Mimi, et al.
Publicado: (2022)

Assessment of Haemostasis in Disseminated Intravascular Coagulation by Use of Point-of-Care Assays and Routine Coagulation Tests, in Critically Ill Patients; A Prospective Observational Study
por: Kander, Thomas, et al.
Publicado: (2016)

Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4‐factor prothrombin complex concentrates
por: Wiedermann, Christian J.
Publicado: (2020)

Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
por: Onundarson, Pall T., et al.
Publicado: (2021)

Prothrombin: Another Clotting Factor After FV That Is Involved Both in Bleeding and Thrombosis
por: Girolami, Antonio, et al.
Publicado: (2018)

Prothrombin complex concentrate in the management of major bleeding induced by oral anticoagulant therapy
por: AlSheef, Mohammed, et al.
Publicado: (2022)

Vitamin K2 Needs an RDI Separate from Vitamin K1
por: Akbulut, Asim Cengiz, et al.
Publicado: (2020)

Effects of naturopathic medicines on Multiplate and ROTEM: a prospective experimental pilot study in healthy volunteers
por: Bagge, August, et al.
Publicado: (2016)

Effects of Dextran-70 and Albumin on Coagulation in Experimental Hemorrhage in the Guinea Pig
por: Schött, Ulf, et al.
Publicado: (2018)

Dose-response effects of omega-3 on platelet aggregation: an observational study
por: Kander, Thomas, et al.
Publicado: (2018)

Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3)
por: Abdoellakhan, Rahat A, et al.
Publicado: (2018)

The Bone—Vasculature Axis: Calcium Supplementation and the Role of Vitamin K
por: Wasilewski, Grzegorz B., et al.
Publicado: (2019)

Reversal of Vitamin K Antagonist Therapy by Prothrombin Complex Concentrate before Thrombolysis for Acute Stroke
por: Chausson, Nicolas, et al.
Publicado: (2013)

Three- versus four-factor prothrombin complex concentrate for the reversal of warfarin-induced bleeding
por: Holt, Tara, et al.
Publicado: (2018)

The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
por: Hoffman, Maureane, et al.
Publicado: (2018)

Effectiveness of prothrombin complex concentrate for the treatment of bleeding: A systematic review and meta‐analysis
por: van den Brink, Daan P., et al.
Publicado: (2020)

Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients
por: Wang, Lang, et al.
Publicado: (2020)

Safety and efficacy of a strategy of vitamin K antagonist reversal with prothrombin complex concentrates compared to vitamin K in patients with hip fracture
por: Jay-Caillierez, Lucille, et al.
Publicado: (2021)

Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
por: Schenk, Bettina, et al.
Publicado: (2018)

Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients
por: Staudinger, T., et al.
Publicado: (1999)

Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage
por: Wong, Yun
Publicado: (2011)

Optimal Dosage and Administration Practices for Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate
por: Rhoney, Denise H., et al.
Publicado: (2020)

Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model
por: Kaspereit, F., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ud93r48sau9jtg5o4vvve52bc0